Browse Pet Safety Reports
16,698 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,698 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,698 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Apr 11, 2018 | Human | Unknown | Selamectin | Eye irritation; Allergic reaction | Ongoing |
| Apr 11, 2018 | Human | Unknown | Selamectin | Throat irritation; Nasal cavity disorder NOS | Outcome Unknown |
| Apr 9, 2018 | Human | Unknown | Tulathromycin | Unclassifiable adverse event | Outcome Unknown |
| Apr 7, 2018 | Human | Unknown | Moxidectin | Injection site reaction NOS; Diarrhoea; Accidental exposure | Recovered/Normal |
| Apr 7, 2018 | Human | Unknown | Imidacloprid; Moxidectin | Malodour | Recovered/Normal |
| Apr 7, 2018 | Human | Unknown | Imidacloprid; Moxidectin | Burning mouth sensation | Recovered/Normal |
| Apr 6, 2018 | Human | Unknown | Oclacitinib Maleate | Pruritus | Outcome Unknown |
| Apr 6, 2018 | Human | Unknown | Tulathromycin | Fainting | Ongoing |
| Apr 6, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site pain | Ongoing |
| Apr 3, 2018 | Human | Unknown | Enrofloxacin | Injection site pain; Injection site tingling | Outcome Unknown |
| Apr 3, 2018 | Human | Unknown | Florfenicol; Terbinafine; Betamethasone | Eye irritation | Ongoing |
| Apr 3, 2018 | Human | Unknown | Afoxolaner | Nausea; Emesis; Accidental exposure | Outcome Unknown |
| Apr 2, 2018 | Human | Unknown | Imidacloprid; Moxidectin | Bad taste; Oral cavity disorder NOS; Feeling anxious; Tachycardia | Outcome Unknown |
| Apr 2, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Apr 1, 2018 | Human | Unknown | Thiamazole | Fatigue; Diarrhoea; General pain (see other SOCs for specific pain); Loss of ... | Ongoing |
| Mar 31, 2018 | Human | Unknown | Afoxolaner | Welt | Outcome Unknown |
| Mar 31, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Difficulty of Use; Dispenser, Abnormal; Pat... | Recovered/Normal |
| Mar 28, 2018 | Human | Unknown | Florfenicol; Terbinafine; Betamethasone | Sore eye | Ongoing |
| Mar 28, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Containers, Leaking | Recovered/Normal |
| Mar 28, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Mar 27, 2018 | Human | Unknown | Imidacloprid; Moxidectin | Tingling sensation; Application site tingling; Accidental exposure | Recovered/Normal |
| Mar 26, 2018 | Human | Unknown | Imidacloprid; Moxidectin | Tingling sensation; Accidental exposure | Recovered/Normal |
| Mar 26, 2018 | Human | Unknown | Fluralaner Chew Tablets | Facial rash (For urticaria see Immune SOC); Swollen face (see also 'Skin') | Ongoing |
| Mar 26, 2018 | Human | Unknown | Tilmicosin | Thoracic pain; Accidental exposure | Recovered/Normal |
| Mar 24, 2018 | Human | Unknown | Selamectin | Nasal discharge; Eye itching; Accidental exposure | Outcome Unknown |
| Mar 22, 2018 | Human | Unknown | Tildipirosin Injectable | Dizzy spell; Loss of vision | Recovered/Normal |
| Mar 21, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Mar 21, 2018 | Human | Unknown | Imidacloprid; Moxidectin | Bad taste; Accidental exposure | Recovered/Normal |
| Mar 21, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Mar 21, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Mar 19, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Solution, Abnormal | Recovered/Normal |
| Mar 17, 2018 | Human | Unknown | Clomipramine | Nervousness | Ongoing |
| Mar 16, 2018 | Human | Unknown | Tildipirosin Injectable | Injection site self trauma | Outcome Unknown |
| Mar 15, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Mar 15, 2018 | Human | Unknown | Bupivacaine Lipsome Injectable Suspen... | Eye irritation; Skin irritation | Recovered/Normal |
| Mar 14, 2018 | Human | Unknown | Levothyroxine Sodium | No sign; Accidental exposure; Hypotension | Recovered/Normal |
| Mar 14, 2018 | Human | Unknown | Tilmicosin | Injection site pain; Injection site swelling; Injection site reddening; Accid... | Outcome Unknown |
| Mar 12, 2018 | Human | Unknown | Afoxolaner | Panic attack; Accidental exposure | Outcome Unknown |
| Mar 11, 2018 | Human | Unknown | Ivermectin; Clorsulon | Injection site complication NOS; Accidental exposure | Recovered/Normal |
| Mar 11, 2018 | Human | Unknown | Selamectin | Itchy skin; Rash | Outcome Unknown |
| Mar 9, 2018 | Human | Unknown | Florfenicol; Terbinafine Hydrochlorid... | Eye irritation; Eye redness | Recovered/Normal |
| Mar 8, 2018 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Mar 8, 2018 | Human | Unknown | Eprinomectin | Injection site swelling | Recovered/Normal |
| Mar 7, 2018 | Human | Unknown | Milbemycin Oxime; Praziquantel | Stomach upset; Accidental exposure | Ongoing |
| Mar 6, 2018 | Human | Unknown | Ceftiofur Crystalline Free Acid | Injection site reaction NOS; Injection site swelling; Injection site reddenin... | Outcome Unknown |
| Mar 6, 2018 | Human | Unknown | Spinosad; Milbemycin Oxime | Walking difficulty; Headache; Nausea; Speech impairment NOS; Accidental exposure | Ongoing |
| Mar 6, 2018 | Human | Unknown | Bupivacaine Lipsome Injectable Suspen... | Eye numbness | Recovered/Normal |
| Mar 6, 2018 | Human | Unknown | Dinoprost Tromethamine | Uterine spasm | Ongoing |
| Mar 5, 2018 | Human | Unknown | Tilmicosin | Injection site bleeding; Accidental exposure | Recovered/Normal |
| Mar 5, 2018 | Human | Unknown | Maropitant Citrate | Abdominal cramp; Diarrhoea; Nausea | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.